TD Cowen analyst Dan Brennan reiterated a Buy rating on Sophia Genetics SA (NASDAQ: SOPH).The analyst commented, "We attended a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE